Condition: Gynecologic Cancer · Hereditary Cancer Syndrome · Sponsor: Weill Medical College of Cornell University
In this study, the investigators aim to compare a mobile health platform, known as a 'chatbot,' that leverages artificial intelligence and natural language processing to scale communication, to 'usual care' that patients would receive. This comparison will enable the investigators to determine if the chatbot system can improve rates of recommendation for genetic testing among patients at elevated risk of harboring a familial cancer syndrome in an all-Medicaid gynecology clinic. Furthermore, the investigators aim to evaluate facilitators of inequity in regard to patient access to and utilization of genetic testing services.
This description comes directly from the study's public registry record.
Melissa K Frey, MD, MS · 212-746-3049 · mkf2002@med.cornell.edu
Elise Barrow, MPH · ecb4001@med.cornell.edu
Always discuss trial participation with your own doctor first.
| NYP Brooklyn Methodist Hospital | Brooklyn, New York, United States | Recruiting |
| NYP Lower Manhattan Hospital | New York, New York, United States | Recruiting |
| Weill Cornell Medicine | New York, New York, United States | Recruiting |
| NYP Medical Group Queens | Queens, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05562778